Acadian Asset Management LLC Spero Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $32.5 Billion
- Q2 2024
A detailed history of Acadian Asset Management LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,071,860 shares of SPRO stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,071,860
Previous 762,598
40.55%
Holding current value
$1.47 Million
Previous $1.31 Million
6.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SPRO
# of Institutions
51Shares Held
15.5MCall Options Held
500Put Options Held
1K-
Anson Funds Management LP Dallas, TX3.75MShares$5.14 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$2.43 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.85 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny976KShares$1.34 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX919KShares$1.26 Million0.23% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $48M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...